title: Is it Possible to Predict Benefit from 5FU Adjuvant Therapy in Stage III Colon Cancer Patients?
authors.affiliation: Department of Medical Sciences, University of Trieste-Trieste, Italy.
authors.forename: Serena
authors.initials: S
authors.lastname: Bonin
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D003110:Colonic Neoplasms; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009154:Mutation; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D005472:Fluorouracil